PATENT CLAIM ANALYSIS

Application Number: 15910876
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "005900"]

Abstract:
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.

Claim (Index 2):
The method of  claim 1  wherein the ultrarapid acting insulin preparation is administered by inhalation.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.45161
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12539459', '13351855', '14102383', '13357821', '15421743']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8446049513831478
- 35 USC 102 Novelty (BERT): 0.6748656708221882
- Combined Prediction Score: 0.8276310233270519
- Mean Citation Score: 697.768908
- Max Citation Score: 723.9169
- Similarity Product: 642.0341805651548

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test